An important component of inflammation in our bodies is the inflammasome complex, which converts pro versions of cytokines like IL-1β and IL-18, which aids in cancer progression; thus, investigating various inflammasome inhibitors such as MCC950, CY-09, and others is critical [130]. Here, IL18 is linked to cancer.